Chemed (CHE) Other Non-Current Liabilities (2009 - 2026)

Chemed has reported Other Non-Current Liabilities for 18 years, with the latest figure at $13.5 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities rose 3.61% year-over-year to $13.5 million; the trailing twelve-month figure through Mar 2026 stood at $13.5 million (up 3.61% YoY), and the FY2025 full-year result was $13.3 million, changed 0.25% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $13.5 million, up from $13.3 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $13.5 million in Q1 2026, with the low at $10.3 million in Q1 2022.
• Average Other Non-Current Liabilities over 5 years is $12.7 million, with a median of $13.0 million recorded in 2024.
• Peak annual rise in Other Non-Current Liabilities reached 25.87% in 2022, while the deepest fall reached 61.35% in 2022.
• Tracing CHE's Other Non-Current Liabilities over 5 years: stood at $12.1 million in 2022, then rose by 7.14% to $13.0 million in 2023, then gained by 2.81% to $13.4 million in 2024, then declined by 0.25% to $13.3 million in 2025, then advanced by 1.41% to $13.5 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $13.5 million (Q1 2026), $13.3 million (Q4 2025), and $13.4 million (Q3 2025), per Business Quant data.

Peer Comparison